Last update 01 Nov 2024

Hemoglobins x BMP6

Basic Info

Related Targets
HemoglobinsBMP6

Related

1
Drugs associated with Hemoglobins x BMP6
CSJ-137
Target
BMP6 x Hemoglobins
Mechanism
BMP6 inhibitors [+1]
Active Org.
Novartis Pharma AG
Originator Org.
Novartis Pharma AG
Active Indication
Anemia, Iron-Deficiency
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Hemoglobins x BMP6
NCT02570854 / CompletedPhase 1
A First-in-human, Two-part (Open Label, and Randomized/Double Blind/Placebo Controlled), Single- and Repeat-dose Study of CSJ137 in Erythropoietin-treated Chronic Hemodialysis Patients With Functional Iron-deficiency Anemia
100 Clinical Results associated with Hemoglobins x BMP6
Login to view more data
100 Translational Medicine associated with Hemoglobins x BMP6
Login to view more data
0 Patents (Medical) associated with Hemoglobins x BMP6
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free